Product Information
FINGOLIMOD 0.5 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $2.0973 per EA under NDC 65862095230. Its NADAC has been published 68 times since May 7, 2025.
FDA first approved this application on Feb 28, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862095230
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FINGOLIMOD HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207983FDA Approved
2/28/2024
TE Code
AB
On Market Since
2/28/2024
Pharmacological Classes
Price Statistics
The NADAC for FINGOLIMOD 0.5 MG CAPSULE has been published 68 times since May 7, 2025, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0973 per EA |
|---|---|
| All-time high | $5.7374 (Nov 12, 2025) |
| All-time low | $2.0973 (Aug 19, 2026) |
| 52-week high | $5.7374 |
| 52-week low | $2.0973 |
| Median price | $5.0736 |
| Average price | $4.7398 |
| Largest weekly change | -27.4% (Jul 22, 2026) |
| Weeks tracked | 68 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FINGOLIMOD 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FINGOLIMOD 0.5 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $2.0973 per EA (NDC 65862095230), effective Aug 19, 2026.
How has the price of FINGOLIMOD 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has declined 61.9%. It has been tracked across 68 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for FINGOLIMOD 0.5 MG CAPSULE?
Since May 7, 2025, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has ranged from a low of $2.0973 (Aug 19, 2026) to a high of $5.7374 (Nov 12, 2025), with a median of $5.0736 per EA.
Are there cheaper alternatives to FINGOLIMOD 0.5 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FINGOLIMOD 0.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FINGOLIMOD 0.5 MG CAPSULE?
FINGOLIMOD 0.5 MG CAPSULE (NDC 65862095230) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.